Global Cocaine Intoxication Treatment Industry Set to Eclipse US$ 17.91 Million with 6% CAGR by 2033 | FMI Analysis Reveals

The Global Cocaine Intoxication Treatment Industry is poised for substantial expansion over the next decade, driven by the escalating prevalence of cocaine addiction. A recent report by Future Market Insights (FMI) predicts a noteworthy Compound Annual Growth Rate (CAGR) of 6% from 2023 to 2033, culminating in a remarkable valuation surpassing US$ 17.91 Million.

Cocaine addiction is an alarming public health challenge, impacting millions worldwide and giving rise to concerns related to overdose risks, mental health implications, and broader societal consequences. Despite the absence of FDA-approved medications exclusively designed for treating cocaine intoxication, healthcare professionals currently deploy various off-label medications and diverse therapeutic approaches to address symptoms and facilitate addiction recovery.

Request a Sample of this Report Now! https://www.futuremarketinsights.com/reports/sample/rep-gb-16738

The market for cocaine intoxication treatment includes medications, behavioral therapies, and other interventions designed to support recovery from cocaine addiction and manage the symptoms of intoxication. The global prevalence of cocaine use disorder has been increasing in recent years, with the United States and Europe experiencing significant increases in cocaine-related deaths. This trend is expected to drive demand for cocaine intoxication treatment and support market growth.

Key Takeaways from the Global Cocaine Intoxication Treatment Industry Study

• The Cocaine Intoxication Treatment market expanded at a CAGR of 4% from 2018 to 2022.
• From 2023 to 2033, the market for treating cocaine intoxication is projected to expand at a 6% CAGR.
• The market for treating cocaine intoxication is anticipated to reach US$17.91 million by 2033.
• Hospital pharmacies hold the biggest market share, per the FMI research.
• For the Cocaine Intoxication Treatment market, North America is anticipated to have a 40% market share. With a share of 20% throughout the projection period, it is expected that the East & South Asia market would grow considerably.
• The East & South Asia market is predicted to increase significantly throughout the forecast period, with a share of 20% during the forecast period.

“A series of international level collaborations involving healthcare stakeholders across various institutional settings are fueling further clinical trials and research studies dedicated to discovering Cocaine Intoxication Treatment.” says an FMI analyst

Global Cocaine Intoxication Treatment Industry Competition

Key players in the market include pharmaceutical companies such as Tonix Pharmaceutical, GlaxoSmithKline Plc., Bristol Myers Squibb Company, Pfizer Inc., Novartis AG, Teva Pharmaceuticals Ltd., Zydus Pharmaceuticals, Inc., Sun Pharmaceuticals Industries Ltd., and Advanz Pharmaceuticals, along with healthcare providers and technology companies among other global players.

• Tonix Pharmaceuticals Holding Corp. was awarded a grant in August 2022 by the National Institute on Drug Abuse to aid the advancement of TNX-1300, a recombinant enzyme that targets the treatment of cocaine intoxication. Cocaine abuse can have harmful impacts on multiple bodily systems, primarily the cardiovascular system, and can lead to fatal consequences. TNX-1300 has been demonstrated to counteract the physiological consequences of intravenous cocaine use in previous clinical research. This grant will assist in the ongoing development of TNX-1300 as a treatment for life-threatening cocaine intoxication, which was responsible for more than 24,900 drug overdose fatalities in the United States in 2021.

Click Here to Request Methodology! https://www.futuremarketinsights.com/request-report-methodology/rep-gb-16738

More Insights Available

FMI, in its new offering, presents an unbiased analysis of the global Cocaine Intoxication Treatment market, presenting a historical analysis from 2018 to 2022 and forecast statistics for the period of 2023 to 2033.

The study reveals essential insights based on Drug Class, Route Administration, Distribution Channel & Region.

Key Segments Profiled in the Global Cocaine Intoxication Treatment Industry Survey

Drug Class:

• Phentolamine
• Lorazepam
• Diazepam
• Verapamil
• Morphine

Route of Administration:

• Oral
• Inhalation
• Intravenous
• Nasal

Distribution Channel:

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

 Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube